Corcept Therapeutics Incorporated (CORT)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 127,665 | 135,551 | 436,619 | 335,812 | 476,892 |
| Short-term investments | US$ in thousands | 255,669 | 232,670 | 365,343 | 145,918 | 364,506 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 140,773 | 104,505 | 81,588 | 6,908 | 10,554 |
| Quick ratio | 2.72 | 3.52 | 9.83 | 69.74 | 79.72 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($127,665K
+ $255,669K
+ $—K)
÷ $140,773K
= 2.72
The quick ratio of Corcept Therapeutics Incorporated has shown a declining trend over the years, indicating a potential decrease in the company's ability to meet its short-term obligations with its most liquid assets. As of December 31, 2020, the quick ratio was 79.72, reflecting a strong liquidity position. However, by December 31, 2024, the quick ratio had decreased to 2.72, suggesting a significant reduction in liquidity and potentially raising concerns about the company's short-term financial health. It is important for stakeholders to monitor this trend closely to assess the company's ability to cover its short-term liabilities efficiently.
Peer comparison
Dec 31, 2024